Similarly, a total of 75, 59, 56 and 53 differential metabolites between the PRE‐treated and AD model groups were identified in Hp, Th, Hth and Cc regions, respectively (Figure S5 and Tables S3–S6). This evidence concerns the gene CXCR1 and Alzheimer disease.